CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.
Hsieh CC, Hsu SH, Lin CY, Liaw HJ, Li TW, Jiang KY, Chiang NJ, Chen SH, Lin BW, Chen PC, Chan RH, Lin PC, Yeh YM, Shen CH.
Hsieh CC, et al. Among authors: chan rh.
Br J Cancer. 2022 Nov;127(9):1615-1628. doi: 10.1038/s41416-022-01946-9. Epub 2022 Aug 23.
Br J Cancer. 2022.
PMID: 35999268
Free PMC article.